Jan 3, 2021
The National Institute of Standards and Technology (NIST) has awarded QDTI a Phase I SBIR contract to support the development of a NV imaging-based instrument for single magnetic nanoparticle analysis. Magnetic nanoparticles are used in a broad range of industries but find particularly valuable application to biomedical diagnostics and therapy. Magnetic bead products for immunoassays comprise a $1 billion market. A lack of cost-effective commercial technology for high-throughput single-particle analysis impedes robust quality control, which hinders reproducibility and novel innovative uses for magnetic particles. QDTI’s novel particle analysis system with low cost and high throughput will permit high quality, high value magnetic products to reach wider markets.